Evidence map›Paper›PMID 30151407›Full record

ArticleOpen forum infectious diseases2018

Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort.

Sara N Levintow, Nwora Lance Okeke, Stephane Hué, Laura Mkumba, Arti Virkud, Sonia Napravnik, Joseph Sebastian, William C Miller, Joseph J Eron, Ann M Dennis

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sara N LevintowDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.ORCID 0000-0001-5558-526X
Nwora Lance OkekeDivision of Infectious Diseases, Duke University, Durham, North Carolina.
Stephane HuéLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Laura MkumbaDivision of Infectious Diseases, Duke University, Durham, North Carolina.
Arti VirkudDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Sonia NapravnikDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Joseph SebastianCampbell University School of Osteopathic Medicine, South Lillington, North Carolina.
William C MillerDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio.
Joseph J EronDepartment of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
Ann M DennisDivision of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
Using Phylogenetics to Elucidate HIV Transmission Patterns and Inform PreventionK08AI112432 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DENNIS, ANN · 2014 to 2017
$697k
NCATS NIH HHS UL1 TR001111NIAID NIH HHS K08 AI112432NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI064518NIAID NIH HHS T32 AI070114
6 · The paper itself

Abstract

backgroundTransmitted drug resistance (TDR) compromises clinical management and outcomes. Transmitted drug resistance surveillance and identification of growing transmission clusters are needed in the Southeast, the epicenter of the US HIV epidemic. Our study investigated prevalence and transmission dynamics in North Carolina.

methodsWe analyzed surveillance drug resistance mutations (SDRMs) using partial

resultsAmong 1658 patients with pretherapy resistance testing, ≥1 SDRMs was identified in 199 patients, with an aggregate TDR prevalence of 12% (95% confidence interval, 10% to 14%) increasing over time (

conclusionsModerate TDR prevalence persists in North Carolina, predominantly driven by NNRTI resistance. Most TDR cases were identified in transmission clusters, signifying multiple local transmission networks and TDR circulation among ART-naïve persons. Transmitted drug resistance surveillance can detect transmission networks and identify patients for enhanced services to promote early treatment.

Indexed as

antiretroviral therapydrug resistanceHIV-1molecular epidemiologySoutheastern United States

Identifiers

PMID30151407
PMCPMC6101542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.